MX2011008398A - Lactobacillus helveticus cncm i-4095 y el control del peso. - Google Patents
Lactobacillus helveticus cncm i-4095 y el control del peso.Info
- Publication number
- MX2011008398A MX2011008398A MX2011008398A MX2011008398A MX2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A
- Authority
- MX
- Mexico
- Prior art keywords
- lactobacillus helveticus
- weight control
- helveticus cncm
- present
- obesity
- Prior art date
Links
- 240000002605 Lactobacillus helveticus Species 0.000 title abstract 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 title abstract 2
- 229940054346 lactobacillus helveticus Drugs 0.000 title abstract 2
- 238000004260 weight control Methods 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 3
- 235000020824 obesity Nutrition 0.000 abstract 3
- 230000037221 weight management Effects 0.000 abstract 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
En general, la presente invención se refiere al campo de la obesidad. En particular, la presente invención se refiere al uso de probióticos para apoyar el manejo del peso y para tratar o prevenir la obesidad. Una modalidad de la presente invención se refiere al uso del Lactobacillus helveticus CNCM I-4095 para la preparación de una composición para apoyar el manejo del peso, promover la pérdida de peso y/o para tratar la obesidad.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09152434A EP2216034A1 (en) | 2009-02-10 | 2009-02-10 | Lactobacillus helveticus CNCM I-4095 and weight control |
PCT/EP2010/051360 WO2010091991A1 (en) | 2009-02-10 | 2010-02-04 | Lactobacillus helveticus cncm i-4095 and weight control |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011008398A true MX2011008398A (es) | 2011-09-01 |
Family
ID=40749130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011008398A MX2011008398A (es) | 2009-02-10 | 2010-02-04 | Lactobacillus helveticus cncm i-4095 y el control del peso. |
Country Status (8)
Country | Link |
---|---|
US (1) | US8454949B2 (es) |
EP (2) | EP2216034A1 (es) |
CN (1) | CN102316882B (es) |
AU (1) | AU2010213007B2 (es) |
BR (1) | BRPI1008355A2 (es) |
CL (1) | CL2011001939A1 (es) |
MX (1) | MX2011008398A (es) |
WO (1) | WO2010091991A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2216034A1 (en) * | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus helveticus CNCM I-4095 and weight control |
RU2453593C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии |
CN102329762A (zh) * | 2011-11-01 | 2012-01-25 | 内蒙古农业大学 | 一种瑞士乳杆菌h9及其用途 |
CN102329763A (zh) * | 2011-11-01 | 2012-01-25 | 内蒙古农业大学 | 一种瑞士乳杆菌h9及其在制备发酵乳中的用途 |
BR112014024159A2 (pt) | 2012-03-29 | 2017-06-20 | Therabiome Llc | Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice. |
US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
DK2979088T3 (en) * | 2013-03-28 | 2018-08-13 | Nestec Sa | ALFA-KETO ISOVALATED AS A BIOMARKER OF PREBIOTIC EFFECTS FOR WEIGHT-INCREASING PREVENTION |
CN104771416B (zh) * | 2014-01-10 | 2020-11-10 | 景岳生物科技股份有限公司 | 用于控制体重的罗伊氏乳杆菌gmnl-263组合物及其用途 |
KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
WO2018136884A1 (en) * | 2017-01-23 | 2018-07-26 | The Regents Of The University Of California | Compositions and methods for treating obesity and inducing weight loss |
CN109112083B (zh) * | 2018-08-01 | 2020-08-04 | 江南大学 | 一种高产辛酸的瑞士乳杆菌及其应用 |
TWI713972B (zh) * | 2019-01-14 | 2020-12-21 | 大江生醫股份有限公司 | 改善呼吸道健康之益生菌株及其組合物與用途 |
KR102495246B1 (ko) * | 2022-08-02 | 2023-02-14 | (주)헥토헬스케어 | 체지방 감소 활성을 갖는 락토바실러스 헬베티쿠스 bcc-lh-04 및 이를 포함하는 조성물 |
CN117757702B (zh) * | 2024-02-21 | 2024-07-16 | 中科微智(北京)生物科技有限公司 | 一株瑞士乳杆菌及其在控制血糖中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004519241A (ja) * | 2001-03-09 | 2004-07-02 | ソシエテ デ プロデユイ ネツスル ソシエテ アノニム | 高齢化に伴う生理的障害を改善し寿命を延ばす組成物 |
ITMI20020399A1 (it) * | 2002-02-28 | 2003-08-28 | Ct Sperimentale Del Latte S P | Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici |
EP1344458A1 (en) * | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
EP1388295A1 (en) * | 2002-08-07 | 2004-02-11 | Nestec S.A. | Cereal based food product comprising DHA |
PT1820849E (pt) | 2006-02-20 | 2009-04-24 | Gervais Danone Sa | Novas estirpes de lactobacillus helveticus |
JP2007284360A (ja) | 2006-04-13 | 2007-11-01 | Mitsukan Group Honsha:Kk | 乳酸菌由来のppar依存的遺伝子転写活性化組成物 |
NZ575469A (en) * | 2006-09-04 | 2012-05-25 | Megmilk Snow Brand Co Ltd | Agent comprising lactobacillus for accelerating the increase in and/or preventing the decrease in blood adiponectin level, and visceral fat accumulation inhibitor |
EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
EP2216034A1 (en) * | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus helveticus CNCM I-4095 and weight control |
-
2009
- 2009-02-10 EP EP09152434A patent/EP2216034A1/en not_active Withdrawn
-
2010
- 2010-02-04 EP EP10702320A patent/EP2396013A1/en not_active Withdrawn
- 2010-02-04 AU AU2010213007A patent/AU2010213007B2/en not_active Ceased
- 2010-02-04 BR BRPI1008355A patent/BRPI1008355A2/pt not_active IP Right Cessation
- 2010-02-04 CN CN201080007306XA patent/CN102316882B/zh not_active Expired - Fee Related
- 2010-02-04 US US13/147,687 patent/US8454949B2/en not_active Expired - Fee Related
- 2010-02-04 WO PCT/EP2010/051360 patent/WO2010091991A1/en active Application Filing
- 2010-02-04 MX MX2011008398A patent/MX2011008398A/es active IP Right Grant
-
2011
- 2011-08-10 CL CL2011001939A patent/CL2011001939A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2396013A1 (en) | 2011-12-21 |
WO2010091991A1 (en) | 2010-08-19 |
CL2011001939A1 (es) | 2012-01-20 |
AU2010213007B2 (en) | 2014-08-07 |
BRPI1008355A2 (pt) | 2016-02-23 |
EP2216034A1 (en) | 2010-08-11 |
US20110293568A1 (en) | 2011-12-01 |
CN102316882A (zh) | 2012-01-11 |
CN102316882B (zh) | 2013-09-18 |
AU2010213007A1 (en) | 2011-08-25 |
US8454949B2 (en) | 2013-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011008398A (es) | Lactobacillus helveticus cncm i-4095 y el control del peso. | |
MX2011008400A (es) | Lactobacillus rhamnosus cncm i-4096 y el control del peso. | |
MX2011008399A (es) | Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso. | |
MY155516A (en) | Lactobacillus rhamnosus and weight control | |
MX2012003612A (es) | Bifidobacterium longum atcc baa-99 (bl999) y control de peso. | |
ATE537707T1 (de) | Lactobacillus paracasei und gewichtskontrolle | |
PT2626076T (pt) | Utilizações terapêuticas de lactobacillus salivarus ls01 22775 | |
PL2498789T3 (pl) | Probiotyczny szczep bifidobacterium | |
GB2465051B (en) | Probiotic bifidobacterium strains | |
HK1141554A1 (en) | Probiotic bifidobacterium strains | |
MY156849A (en) | Novel lactobacillus plantarum and composition comprising the same | |
PT2332520T (pt) | Lactobacillus paracasei para tratar os pontos de senescência e/ou melasma | |
PL2429556T3 (pl) | Mleka typu "growing up" zawierające probiotyczne mikroorganizmy | |
MX350234B (es) | Compuestos de enlace especificos de bacterias gram-positivas. | |
PL2475764T3 (pl) | Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii | |
PL2485743T3 (pl) | Szczepy Lactobacillus plantarum jako czynniki hipocholesterolemiczne | |
HK1156343A1 (en) | A denitrifying microbial bacteria formulation, the method of preparation, and uses thereof | |
PL2753687T3 (pl) | Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium | |
PL2276498T3 (pl) | Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii | |
MY158310A (en) | Prevention and treatment of allergic diarrhoea | |
PL2568815T3 (pl) | Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei | |
MX2015005898A (es) | Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo. | |
AP2012006139A0 (en) | Composition comprising strains of lactobacillus fermentum. | |
MX2015005897A (es) | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal. | |
MX346332B (es) | Cepas probioticas para aumentar la resistencia transepitelial. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |